Rostaporfin

N/A

Report date: 2025/08/29 20:01:31
NME

Base Information

Drug NameRostaporfin
Drug Alias NamePhotrexPurlytinPhotoPoint SnET2Rostaporfin-PDTSn(IV) etiopurpurin +[10] 
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsMacular DegenerationSarcoma, KaposiHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMiravant Medical Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMiravant Pharmaceuticals IncClinical Solutions
Active IndicationsN/A
Inactive IndicationsMacular DegenerationSarcoma, KaposiHIV Infections

Other Information

ATC CodeN/A
Related LinksKEGG